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Recent reports comparing the IAS and RSM have shown that the tonic smooth muscle of the IAS expresses significantly higher levels of the renin-angiotensin system (RAS) components and angiotensin II (ANG II) than in the RSM (7) (8) (9) . In addition, inhibitors of ANG II receptor subtype 1 and ANG II converting enzyme cause a significant fall in the IAS tone. Interestingly, similar data have been obtained in the human lower esophageal sphincter (LES) (3) . These data suggest that the RAS pathway may be responsible for ϳ30% of the basal tone in the IAS. However, factors responsible for the majority of the basal tone in the IAS are not known. Based on the studies of Cao et al. (2, 12) in the LES, we considered it important to determine the role of phospholipase A 2 (PLA 2 ) pathway in the IAS tone.
PLA 2 plays an important role for a broad range of diverse cellular responses, including digestion and metabolism of membrane phospholipids, signal transduction, and the generation of eicosanoid precursors (27) . PLA 2 belongs to a large group of enzymes that hydrolyze fatty acids from the sn-2 position of glycerol-based phospholipids. Mammalian cells generally contain more than one PLA 2 , each of which is regulated independently and exerts a distinct action (19) .
PLA 2 are generally classified into two groups based on their location in the cell: extracellular or secreted (sPLA 2 ; low molecular mass, 14 -29 kDa) (10) and intracellular or cytosolic (cPLA 2 ; high molecular mass, 80 -85 kDa) (27) . The cPLA 2 are further subdivided into two isoforms, the 85-kDa Ca 2ϩ sensitive cPLA 2 and the 80-kDa Ca 2ϩ -insensitive PLA 2 (iPLA 2 ).
In the present studies, we evaluated the role of PLA 2 in the genesis of IAS tone via the use of the selective inhibitors of cPLA 2 and sPLA 2 isoforms. We also examined the ability of PLA 2 to generate tone in the RSM. We tested the presence of cPLA 2 and sPLA 2 in IAS and RSM at the genetic and protein levels. Because the anorectal smooth muscle activities are entirely Ca 2ϩ dependent (5), studies focused on the cPLA 2 and sPLA 2 isoforms in the IAS vs. RSM. Results showing higher PLA 2 levels and activity in the IAS vs. RSM, selective decrease in the IAS tone by the sPLA 2 inhibitors, and a number of other systematic studies suggest that sPLA 2 plays an important role in the genesis of spontaneous tone in the IAS.
MATERIALS AND METHODS
Tissue preparation. Male Sprague-Dawley rats (300 -350 g) were killed by decapitation, and IAS and RSM strips were prepared as described before (8) . Briefly, circular IAS and RSM strips (ϳ0.5 mm ϫ 7 mm) were prepared in the oxygenated Krebs physiological solution (KPS). The composition of KPS was as follows (in mM): 118.07 NaCl, 4.69 KCl, 2.52 CaCl 2, 1.16 MgSO4, 1.01 NaH2PO4, 25 NaHCO 3, and 11.10 glucose.
The experimental protocol of the study was approved by the Institutional Animal Care and Use Committee of Thomas Jefferson University in accordance with the recommendations of the American Association for the Accreditation of Laboratory Animal Care.
Measurement of isometric tension. The smooth muscle strips were transferred to 2-ml muscle baths containing oxygenated KPS at 37°C.
One end of the smooth muscle strips was anchored at the bottom of the muscle bath, while the other end was connected to a force transducer (model FT03; Grass Instruments, Quincy, MA). Isometric tension was measured by the PowerLab/8SP data-acquisition system and recorded with Chart 4.1.2 (ADInstruments, Australia). Each smooth muscle strip was initially stretched to a tension of 0.7 g, followed by 60 min of equilibration period. During this period, the smooth muscle strips were replenished with fresh KPS every 20 min. The identity of the IAS smooth muscle strips was confirmed by the development of spontaneous tone and relaxation in response to electrical field stimulation (EFS; 0.5-20 Hz, 0.5-ms pulse, 10 V, 4-s train) (23) .
Drug responses. We examined the effects of different PLA 2 inhibitors: 4-bromophenacyl bromide (BPB); 1-hexadecyl-3-(trifluoroethyl)-sn-glycero-2-phosphomethanol lithium (MJ33), a selective inhibitor of the sPLA 2; arachidonyl trifluoromethyl ketone (AA-COCF3), a selective inhibitor of the cPLA2; and of bromoenol lactone (BEL), a selective inhibitor of iPLA2 (all 0.01-100 M). Decreases in the IAS tone were normalized by the 50 mM EDTA responses (percent maximal or 100% decrease), as described previously, at the end of each experiment (8) .
To test the ability of PLA 2 to generate tone, we examined the effect of exogenously administered sPLA2 (0.0001-1 U/ml) in IAS and RSM strips before and after the inhibitors. To compare results with purely phasic smooth muscle model, we also included anococcygeus smooth muscle (ASM) in these series of experiments. Responses were measured and normalized by the maximal contraction induced by 100 M bethanechol (8) .
PLA 2 activity. PLA2 activity in the IAS and RSM was determined using a dithiolester analog of phosphatidylcholine (PC) (diheptanoyl thio-PC substrate) as the substrate. Upon hydrolysis, the thio ester bond at the sn-2 position by PLA 2 releases free thiols that can be measured by colorimetric assay using 5,5Ј-dithiobis(2-nitrobenzoic acid) (DTNB), as described previously (13) . Briefly, IAS and RSM tissues were homogenized in PLA 2 assay buffer (25 mM Tris ⅐ HCl, pH 7.5, containing 10 mM CaCl2, 100 mM KCl, 0.3 mM Triton X-100, and 1 mg/ml BSA). This assay buffer was also used for reconstitution of substrate and dilution of samples before assaying. A 10 mM DTNB solution was prepared in 0.4 M Tris ⅐ HCl (pH 8.0). Following protein determination, the samples were diluted to a final loading of 0.1 g/l.
For assaying samples, 10-l DTNB, 10-l sample (or 10 l of assay buffer for blank), and 5-l assay buffer (when performing inhibitor experiments, 5 l of inhibitor were added instead of assay buffer) were mixed. Reactions were initiated by adding 200 l of substrate solution. Absorbance was recorded at 414 nm (A 414) at different times. A standard curve for determining the optimum substrate concentrate was obtained using 0.5 g/ml of PLA2. PLA2 activity was calculated based on the following equation: RNA isolation and RT-PCR analysis. Total RNA was isolated from the IAS and RSM, purified by the acid guanidine-phenol-chloroform method (4), and then quantified by measurement of absorbance at 260 http://ajpgi.physiology.org/ nm in a spectrophotometer. Total RNA (2.0 g) was subjected to first-strand cDNA synthesis using oligo(dT) primers (Promega, Madison, WI) and Omniscript RT Kit (Qiagen, Germantown, MD) in a final volume of 20 l at 42°C for 60 min. PCR primers specific for cPLA 2, sPLA2, and ␣-actin cDNA were designed as shown in Table 1 . PCR was performed in a Promega 2ϫ master mix (Promega, Madison, WI) in a final volume of 25 l, using a Perkin-Elmer thermal cycler (PerkinElmer Life and Analytical Sciences). The PCR conditions consisted of 94°C for 2 min, followed by 35 cycles of 94°C for 30 s (denaturation), 59°C for 30 s (annealing), and 72°C for 1 min (extension). In the end, it was allowed a final extension at 72°C for 7 min.
The PCR products were separated on 1.5% (wt/vol) agarose gel containing ethidium bromide and were visualized with UV light. The relative densities of cPLA 2 and sPLA2 were calculated by normalizing the integrated optical density (IOD) of each blot with that of ␣-actin. , and ASM (no activity and frank contraction with EFS; C), and their responses to EFS. Bottom: responses of these respective tissues to EFS in the presence of sPLA2 (1 U/ml). A: in the IAS, sPLA2 increases tone that relaxes normally in response to EFS. B: in the RSM, sPLA2 causes the development of tone that undergoes relaxation following EFS. C: in contrast, in the ASM, sPLA2 produces no tone, and there is frank contraction in response to EFS similar to the control. Based on this data, we suggest that sPLA2 has the ability to generate tone in selected smooth muscle.
Western blot analysis. Western blot studies were performed to determine the relative distribution of cPLA 2 and sPLA2, as described before (9) . Briefly, the IAS and RSM tissues were subjected to homogenization and protein extraction and determination by the method of Lowry et al. (16) . Protein bands were separated by gel electrophoresis and transferred onto a nitrocellulose membrane (NCM) at 4°C.
Nonspecific binding on the NCM was blocked with nonfat milk (5%) in Tris-buffered saline-Tween [composed of 20 mM Tris, pH 7.6, 137 mM NaCl, and 0.1% Tween 20 (TBS-T)] overnight at 4°C. Then the NCM was incubated with the specific primary antibody (rabbit anti-sPLA 2 Ib or rabbit anti cPLA2 at 1:1,000) for 2 h at room temperature. After washing with TBS-T, the NCM was incubated with horseradish peroxidase-labeled secondary antibody (1:10,000) for 1 h at room temperature. The corresponding bands were visualized with enhanced chemiluminescence substrate using the SuperSignal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL) and Hyperfilm MP (Amersham Bioscience).
NCM was then stripped of antibodies using the Restore Western Blot Stripping Buffer (Pierce) for 10 min at room temperature and then reprobed for ␣-actin using the specific primary (mouse IgG 1:10,000 for ␣-actin) and secondary (1:10,000) antibodies. Bands corresponding to different proteins were scanned (SnapSacn.310; Agfa, Ridgefield Park, NJ), and the IODs were determined using Image-Pro Plus 4.0. The relative densities were calculated by normalizing the IOD of each blot with that of ␣-actin.
Intraluminal manometry of the IAS and mean blood pressure. The high-pressure zone of the IAS was identified using slow station pullthrough, and IAS pressures (IASPs) were monitored by the modified approach of de Godoy and Rattan (9) and Terauchi et al. (28) . Mean blood pressure (MBP) was recorded via a catheter (inner diameter 0.38 mm; Clay Adams, Parsippany, NJ), attached to a Statham transducer (Medex, Carlsbad, CA), as previously described (9) .
Data were collected in the basal state and after administration (intravenous) of BPB and MJ33 in doses ranging from 0.1 to 100 nmol/kg. All recordings and analyses were carried out using Chart 5 PowerLab (ADInstruments). Results were calculated as the percent maximal decrease by 60 mol/kg sodium nitroprusside.
Drugs and antibodies. AACOCF 3 (IC50 ϭ 1-8 M), BPB, DTNB, sPLA2 Ib (porcine pancreas), and the antibody for ␣-actin were from Sigma-Aldrich (St. Louis, MO). Anti-sPLA2 Ib was from Millipore (Billerica, MA). All other antibodies were from Santa Cruz (Santa Cruz Biotechnology, Santa Cruz, CA). MJ33 (IC 50 ϭ 1-6 M) was from Axxora (Axxora Life Sciences, San Diego, CA). Diheptanoyl thio-PC and BEL (EC 50 ϭ 1-5 M) were from Cayman (Cayman Chemical, Ann Arbor, MI).
Data analysis. Results are expressed as means Ϯ SE. Concentration-response curves were analyzed using a nonlinear interactive fitting program (GraphPad Prism 3.0, Graph Pad Software, San Diego, CA). Inhibitor potencies and maximum responses were expressed as pIC 50 (negative logarithm of the molar concentration of inhibitor producing 50% of the maximal effect) and Imax (maximum inhibition). For in vivo studies, ID50 (the dose that causes 50% inhibition of the IAS tone) of PLA2 inhibitors was also determined.
PLA2 potency and maximum response were expressed as pEC50 (negative logarithm of the molar concentration producing 50% of the maximum) and E max (maximum effect).
Statistical significance was tested by one-way ANOVA, followed by the Dunnett post hoc test when three or more different groups were compared. To compare only two different groups, the unpaired Student t-test was used. A P value Ͻ0.05 was considered to be statistically significant.
RESULTS

Effect of PLA 2 inhibitors on the basal IAS tone.
To evaluate the role of the different PLA 2 isoforms in the basal IAS tone, we first determined the effects of selective and nonselective inhibitors of PLA 2 . The nonselective PLA 2 inhibitor BPB produced a significant and concentration-dependent decrease in IAS basal tone (I max of 60.6 Ϯ 4.0%; pIC 50 of 5.4 Ϯ 0.2; n ϭ 5; Fig. 1A ). The selective inhibitor of the sPLA 2 isoform MJ33 produced a similar effect in the IAS (I max ϭ 53.1 Ϯ 2.1%; pIC 50 ϭ 4.9 Ϯ 0.1, n ϭ 5). However, the selective inhibitors of cPLA 2 and iPLA 2 , AACOCF 3 and BEL, respectively, produced no significant effect (P Ͼ 0.05; n ϭ 5). Actual tracings of the effect of BPB and MJ33 are shown in Fig. 1, B and C. These data suggest that, among different isoforms, sPLA 2 plays a major role in the IAS tone.
In contrast to the IAS, none of the PLA 2 inhibitors examined in concentration range from 10 Ϫ7 M to 10 Ϫ4 M produced any significant effect in the RSM (data not shown).
Effect of exogenous sPLA 2 on the RSM: influence of PLA 2 inhibitors. Exogenous administration of active sPLA 2 I b from porcine pancreas produced a significant (P Ͻ 0.05) and concentration-dependent increase in the force of IAS (E max ϭ 0.015 Ϯ 0.002 g/mg; pIC 50 of 2.3 Ϯ 0.1; n ϭ 5) and RSM (E max ϭ 0.013 Ϯ 0.004 g/mg; pIC 50 of 2.0 Ϯ 0.1; n ϭ 4) in the basal state, as shown in Fig. 2, A and B. This effect of sPLA 2 I b was significantly (P Ͻ 0.05) inhibited by BPB and MJ33. Exogenous sPLA 2 I b , however, produced no significant effect in the ASM. The assay was optimized as described in MATERIALS AND METHODS. Only MJ33 (a selective sPLA2 inhibitor) and BPB (nonselective PLA2 inhibitor) produce a significant (*P Ͻ 0.05; ANOVA) decrease in PLA2 activity in the IAS. Based on this data, we suggest the PLA2 activity in the IAS is primarily because of the sPLA2.
Data suggest that exogenous sPLA 2 I b selectively converts RSM into a tonic smooth muscle comparable to the IAS. To evaluate it further, we compared the effect of EFS on sPLA 2 I b (1 U/ml) increased force in the IAS vs. RSM and ASM. The experiments revealed that, in the presence of sPLA 2 I b , EFS caused relaxation of the RSM (somewhat similar to the IAS). For control to prove the selectivity of sPLA 2 I b , we examined the effects of sPLA 2 I b on the ASM. As shown, the sPLA 2 had no significant effect on the ASM (Fig. 3) .
These data suggest that the basal tone in the IAS may depend on the higher levels and activity of sPLA 2 . Data also suggest the tissue selectivity of sPLA 2 , because the phenomenon cannot be duplicated in the adjoining phasic smooth muscle of the ASM, which lacks the basic machinery for the generation of tone (20) . This discriminative phenomenon has important implications in the genesis of the basal tone, as discussed below.
PLA 2 activity in the IAS vs. RSM in the basal state and following PLA 2 inhibitors. For the specific determinations of sPLA 2 activity, we used a novel reaction approach that measured the effect of sPLA 2 (I b ) at the sn-2 position of glycerophospholipids. This reaction provides precursors for the generation of eicosanoids, with important biological activity in gastrointestinal smooth muscles (2, 13, 21) . Data show that sPLA 2 activity in the IAS is significantly higher than in the RSM. One microgram of IAS sPLA 2 metabolizes 26.5 Ϯ 4.9 mol⅐min Ϫ1 ⅐ml Ϫ1 of diheptanoyl thio-PC vs. 3.2 Ϯ 0.4 mol⅐min Ϫ1 ⅐ml Ϫ1 in the case of RSM (*P Ͻ 0.05; n ϭ 4; Fig. 4, A and B) . Incubation with BPB and MJ33 specifically and significantly decreased the activity of sPLA 2 in the IAS (*P Ͻ 0.05; n ϭ 4; Fig. 4A ), but not in the RSM (P Ͼ 0.05; Fig. 4B) .
Results show that the IAS sPLA 2 is more effective than the RSM sPLA 2 in converting membrane phospholipids. The specificity of the activity assay was further confirmed by the lack of significant effect of other c-and iPLA 2 inhibitors on the basal PLA 2 activity of the IAS.
RT-PCR analyses of sPLA 2 and cPLA 2 in the IAS vs. RSM. Total RNA from the IAS and RSM extracted by the acid guanidine-phenol-chloroform method (13) was reversely transcribed into cDNA and then amplified by PCR using specific primers for the sPLA 2 and cPLA 2 (described in Table 1 ). RT-PCR products were separated by electrophoresis in 1.5% agarose gel, and the relative density was calculated.
The IAS expressed significantly (P Ͻ 0.05; n ϭ 3) higher levels of sPLA 2 as well as cPLA 2 in IAS vs. the RSM at the transcriptional level (shown by the RT-PCR analysis; Fig. 5 , A and C). These data suggest the role of sPLA 2 in the IAS vs. the RSM in converting membrane phospholipids and that the differences in sPLA 2 expression are regulated at the transcriptional level. The significance of higher levels of cPLA 2 at the present time is not known.
Western blot analyses of sPLA 2 and cPLA 2 in the IAS vs. RSM. We evaluated the presence of sPLA 2 and cPLA 2 in protein extracts from IAS and RSM. After separation by gel electrophoresis, protein bands specific for the sPLA 2 and the cPLA 2 were identified by specific antibodies, revealed by chemiluminescence, and recorded in X-ray films. The levels of the sPLA 2 and cPLA 2 in the IAS were significantly (P Ͻ 0.05) higher than in the RSM (*P Ͻ 0.05; n ϭ 3; Fig. 5, B and D) . These data suggest that expression of both sPLA 2 and cPLA 2 is also regulated at the translational level. The significance of higher levels of cPLA 2 is not known at the present time.
Effect of BPB on IASP and MBP in vivo studies. BPB and MJ33 decreased the IASP (I max ϭ 66.7 Ϯ 5.1 and 79.8 Ϯ 8.2%, respectively) in a dose-dependent manner. In this regard, MJ33 (ID 50 ϭ 0.55 nmol/kg, n ϭ 4) was significantly (P Ͻ 0.05) more potent than BPB (ID 50 ϭ 2 nmol/kg, n ϭ 5). In decreasing the IASP, these agents were ϳ100 times more potent than in decreasing the MBP ( Fig. 6; n ϭ 5) . BPB at 0.5 nmol/kg caused a 25 Ϯ 4.2% decrease in IASP (n ϭ 5) without having any significant decrease in MBP (P Ͼ 0.05; 0.7 Ϯ 0.7%; n ϭ 5). Similarly, MJ33 at 0.3 nmol/kg caused a 22.4 Ϯ 5.1% decrease in IASP (n ϭ 4) without affecting the MBP (P Ͼ 0.05; 0.7 Ϯ 0.7%; Fig. 6 ; n ϭ 4). Even if compared at the 10 nmol/kg maximal dose, BPB and MJ33 had limited effects on the MBP (I max 28.6 Ϯ 8.5 and 36.2 Ϯ 5.2%, respectively; n ϭ 5).
DISCUSSION
The IAS plays a major role in the anorectal continence and in the pathophysiology of incontinence, constipation, Hirschsprung's disease, anal fissures, and hemorrhoids (14, 15, 17, 18, 22, 26) . Knowledge of the molecular mechanisms regulating the IAS tone may hold the key in the therapeutic management of such motility disorders. Using a multipronged approach of in vivo, in vitro, and molecular biology, present studies for the first time show that membranous sPLA 2 plays a major upstream role for the basal tone in the IAS smooth muscle.
sPLA 2 is secreted to the external side of the plasma membrane of mammalian cells (10, 19) . In the plasma membrane, PLA 2 converts glycerol-based membrane phospholipids into metabolites (e.g., thromboxanes and PGF 2␣ ) with potent contractile activity in smooth muscles via G protein-coupled receptor activation (2, 12, 27) . In turn, downstream molecular mechanism events, such as RhoA/Rho kinase and PKC, may determine the basal tone in the IAS.
Data show that spontaneous tone in the IAS is directly related to the higher levels and activity of sPLA 2 . Experiments designed to determine the specific molecular nature of PLA 2 (10) revealed the presence of both low molecular mass 14-kDa (sPLA 2 ) and high molecular mass 85-kDa (cPLA 2 ) isoforms in the IAS and the RSM. The IAS expresses significantly higher levels of cPLA 2 and sPLA 2 than the RSM, both at the translational and message levels, as determined by Western blot and RT-PCR analyses (Fig. 5) . However, based on the functional data (discussed below), we speculate that sPLA 2 (specifically group I secreted form) is important for the maintenance of IAS tone.
The IAS has characteristically approximately eightfold higher sPLA 2 activity compared with the RSM (Fig. 4) . Accordingly, in contrast to the potent inhibitory effect of sPLA 2 -selective inhibitor MJ33, the cPLA 2 and iPLA 2 inhibitors AACOCF 3 and BEL produce no significant effect on the PLA 2 activity and in the basal tone in the IAS. sPLA 2 activity in the IAS and RSM was determined using diheptanoyl thio-PC substrate (13) . The method offers particular advantage because it measures the PLA 2 acting at the sn-2 position of glycerophospholipids. Catalysis at the sn-2 position provides precursors for the generation of eicosanoids, with important biological activity in gastrointestinal smooth muscles (2, 21) .
In the IAS, the selective and nonselective inhibitors of PLA 2 , MJ33 and BPB, respectively, produce a significant and concentration-dependent decrease in the basal tone, with similar maximal effects of ϳ60% (Fig. 1) . Data with the use of selective inhibitors suggest that intracellular high molecular mass PLA 2 isoforms (iPLA 2 and cPLA 2 ) may not be important in the genesis of IAS tone, as their selective inhibitors produce no significant effect on the IAS tone (Fig. 1A) . These data are in agreement with previous studies by Cao et al. on the LES of cats (2) and humans (1) and suggest that development of tone in IAS partly depends on the activity of the low molecular mass sPLA 2 . Simultaneous measurements of basal tone and sPLA 2 activity in the present study suggest that the inhibitory effects of BPB on the basal tone in the IAS are because of sPLA 2 inhibition.
Because of the minimal basal tone in the RSM (with the presence of low levels of intracellular molecular signal transduction machinery vs. the IAS), we explored the possibility of RSM (24) as a model for the tone generation by the exogenous sPLA 2 . Interestingly, active sPLA 2 produces concentrationdependent tone in the RSM and an increase in the basal tone in the IAS that is selectively inhibited by BPB and MJ33 (Figs. 2  and 3 ). On the other hand, exogenous sPLA 2 produces no significant effect on the purely phasic ASM. A possible explanation for the diverse effects by sPLA 2 in the partially tonic vs. purely phasic smooth muscles is explained as follows.
While ASM is basically devoid of certain intracellular signal transduction proteins known to be critical for the genesis of myogenic tone, the IAS has high levels, and RSM only has modest levels (20) . Data suggest that sPLA 2 provides an important trigger to functionally upregulate otherwise lower levels of intracellular molecular signal transduction machinery in the RSM to the levels that are capable of producing sustained contraction. Because of the virtual absence of such machinery in the ASM, this phenomenon cannot be demonstrated in the ASM.
It is well known that the IAS smooth muscle relaxes in response to EFS because of nonadrenergic noncholinergic relaxation, and such relaxation in the RSM is depicted primarily in the form of decrease in the ongoing phasic activity (11, 25) . An active relaxation in the RSM may be difficult to demonstrate because of the virtual absence of an active tone. Effects of sPLAs in the RSM offer a unique opportunity to test whether an increase in the tone in the RSM will allow the expression of nonadrenergic noncholinergic relaxation and development of true tone in this smooth muscle. Data reveal that, under control conditions, RSM contracts in response to EFS. Conversely, following treatment with sPLA 2 , because of the generated tone, the RSM relaxes in response to EFS. This suggests that sPLA 2 causes the development of true tone in the RSM (Fig. 3B) . This effect appears to be selective, because exogenous sPLA 2 does not modify either the relaxation in the IAS (Fig. 3A) or contraction in the ASM caused by EFS (Fig. 3C) .
Earlier experiments in the IAS have shown that the local synthesis of ANG II (by the RAS) and subsequent activation of ANG II receptor subtype 1 in the smooth muscle cells are important for ϳ30% of the basal tone (7) (8) (9) . The present studies show that sPLA 2 (most likely via the production of prostanoids) accounts for ϳ60% of the IAS basal tone. Relative contribution by sPLA 2 and RAS and the sPLA 2 pathways and the nature of interaction between them, if any (29, 30) , remain to be determined.
To examine the clinical relevance of sPLA 2 , we monitored the IASP and the MBP before and after the administration of the PLA 2 inhibitors BPB and MJ33. Data show that both inhibitors are significantly more effective in decreasing the IASP than the MBP (Fig. 6) . The selective cPLA 2 and iPLA 2 inhibitors AACOCF 3 and BEL did not produce any significant effect (data not shown). BPB and MJ33 are ϳ100-fold more potent in producing a 25% reduction (ID 25 ) in the IASP than the corresponding decrease in MBP (Fig. 6B) . The ID 25 was used for these calculations because this was the maximal observed decrease in MBP with different inhibitors used in the study. In addition, selective inhibitor of sPLA 2 MJ33 is more potent than the nonselective sPLA 2 inhibitor BPB in decreasing the IASP.
In conclusion, the basal tone in the IAS and possibly in the other tonic smooth muscles is highly dependent on the activity of sPLA 2 . The efficacy and potency of sPLA 2 inhibitors in causing decrease in IASP with minimal cardiovascular effects suggest therapeutic potential of such agents in treating certain motility disorders associated with the hypotensive IAS. Selective sPLA 2 agonists, on the other hand, may have a therapeutic potential in the hypotensive IAS.
